GATA3 and breast carcinoma: We have also shown that the capability of the non-phosphorylable mutant GFP-GATA3-S308A to prevent MPA-induced breast cancer cell proliferation is enhanced compared to its wild-type counterpart, as demonstrated in the in vivo assay in the C4HD preclinical model.